Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2025-12-25 @ 11:58 PM
NCT ID: NCT01093794
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT01093794
Study Brief: Bioequivalence Study of Sitagliptin/Metformin Combination Tablet (MK0431A-122)
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sit 50 mg + Met 500 mg AEs reported in participants after co-administration of 50 mg sitagliptin and 500 mg metformin. None None 0 28 4 28 View
Sit/Met 50 mg/500 mg FDC AEs reported in participants after administration of the sitagliptin/metformin 50 mg/500 mg fixed dose combination (FDC) tablet. None None 0 28 3 28 View
Sit 50 mg + Met 850 mg AEs reported in participants after co-administration of 50 mg sitagliptin and 850 mg metformin. None None 0 28 4 28 View
Sit/Met 50 mg/850 mg FDC AEs reported in participants after administration of sitagliptin 50 mg/metformin 850 mg FDC tablet. None None 0 28 2 28 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Headache None Nervous system disorders MedDRA (14.0) View
Abdominal pain None Gastrointestinal disorders MedDRA (14.0) View
Diarrhea None Gastrointestinal disorders MedDRA (14.0) View
Fever None General disorders MedDRA (14.0) View
Vertigo None Ear and labyrinth disorders MedDRA (14.0) View
Nausea None Gastrointestinal disorders MedDRA (14.0) View
Flatulence None Gastrointestinal disorders MedDRA (14.0) View
Chest pain None General disorders MedDRA (14.0) View
Rash None Skin and subcutaneous tissue disorders MedDRA (14.0) View
Leucocytosis None Blood and lymphatic system disorders MedDRA (14.0) View